Your browser is no longer supported. Please, upgrade your browser.
Settings
SOLY Soliton, Inc. daily Stock Chart
SOLY [NASD]
Soliton, Inc.
Index- P/E- EPS (ttm)-1.05 Insider Own64.39% Shs Outstand16.35M Perf Week8.95%
Market Cap181.16M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float6.35M Perf Month-16.06%
Income-12.40M PEG- EPS next Q- Inst Own6.70% Short Float18.70% Perf Quarter-12.13%
Sales- P/S- EPS this Y-29.10% Inst Trans104.20% Short Ratio3.34 Perf Half Y77.28%
Book/sh0.45 P/B24.62 EPS next Y- ROA-174.80% Target Price- Perf Year-
Cash/sh0.52 P/C21.31 EPS next 5Y- ROE- 52W Range4.12 - 29.00 Perf YTD127.52%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-62.72% Beta-
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin- 52W Low162.38% ATR0.85
Employees7 Current Ratio3.30 Sales Q/Q- Oper. Margin- RSI (14)44.22 Volatility5.37% 8.55%
OptionableNo Debt/Eq0.00 EPS Q/Q-19.00% Profit Margin- Rel Volume0.34 Prev Close11.08
ShortableNo LT Debt/Eq0.00 Earnings- Payout- Avg Volume355.65K Price10.81
Recom- SMA20-5.39% SMA50-10.71% SMA200-6.97% Volume110,957 Change-2.44%
Nov-12-19 08:00AM  Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical Trial PR Newswire
Nov-05-19 09:00AM  Soliton Completes Treatment of All Patients in Pivotal Cellulite Trial PR Newswire
Oct-29-19 08:00AM  Soliton's Recent Positive Data Increases Potential Fibrotic Indications PR Newswire +5.57%
Oct-25-19 08:00AM  Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive Treatment PR Newswire -8.15%
Oct-21-19 08:00AM  Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results PR Newswire +9.24%
Oct-15-19 08:00AM  Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents PR Newswire
Oct-10-19 08:30AM  Soliton Announces $6.25 Million Private Placement PR Newswire +6.68%
Oct-08-19 08:00AM  Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019 PR Newswire
Oct-03-19 08:00AM  Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice PR Newswire +7.77%
Oct-01-19 08:00AM  Soliton Completes Keloid POC Clinical Trial Treatments PR Newswire
Sep-24-19 08:00AM  Soliton Announces Majority of Patients Treated in Pivotal Cellulite Trial; Expects All Patients Treated by November 2019 PR Newswire
Sep-19-19 08:45AM  Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars PR Newswire
Sep-17-19 11:58AM  Do Institutions Own Soliton, Inc. (NASDAQ:SOLY) Shares? Simply Wall St.
08:00AM  Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial PR Newswire
Sep-10-19 08:00AM  Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars PR Newswire
Sep-09-19 08:00AM  Soliton Releases Letter to Shareholders PR Newswire
Sep-04-19 08:00AM  Soliton Announces IRB Approval for Keloid Trial PR Newswire
Aug-29-19 08:00AM  Soliton to Initiate POC Clinical Trials to Treat Fibrotic Scars Using Acoustic Shockwaves; Estimated Market Size of $10 Billion by 2025 PR Newswire
Aug-26-19 08:00AM  Soliton Engages argodesign in Preparation of Commercial Launch of its RAP Device PR Newswire
Aug-20-19 08:00AM  Soliton Announces Positive Results Demonstrated from Longer RAP Treatment PR Newswire +14.01%
Aug-16-19 08:00AM  Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference PR Newswire +7.61%
Aug-14-19 08:00AM  Soliton Treats First Patients in Pivotal Cellulite Trial PR Newswire
Aug-12-19 08:00AM  Soliton Announces Patient Recruitment Has Begun for Pivotal Cellulite Trial PR Newswire +20.98%
Aug-06-19 08:00AM  Soliton Completes Site Enrollment and Conducts Initial Site Training to Start Pivotal Cellulite Trial PR Newswire
Aug-05-19 08:00AM  Soliton Partners with Clear Dermatology and Aesthetics Center to Advance Pivotal Cellulite Trial PR Newswire
Aug-01-19 08:00AM  Soliton Announces Global Nasdaq Partner Sanmina Delivers RAP Device to More Effectively Target Cellulite Reduction for Pivotal Trial PR Newswire
Jul-29-19 08:00AM  Soliton Announces IRB Approval PR Newswire
Jul-25-19 08:00AM  Soliton Enlists Chicago Cosmetic Surgery and Dermatology to Advance Pivotal Cellulite Trial PR Newswire -8.97%
Jul-23-19 08:00AM  Soliton's FDA Cleared Device is Granted Key Patent PR Newswire
Jul-15-19 03:22PM  Why Soliton Stock Is Falling Today Motley Fool -13.48%
08:00AM  Soliton Announces Positive 26-week Cellulite Clinical Trial Results Demonstrate Long-Term Improvement PR Newswire
Jul-10-19 08:00AM  Soliton Expands Clinical Trial Sites to include SkinCare Physicians PR Newswire
Jul-09-19 11:10AM  A Look At Benzinga Pro's Most-Searched Tickers For July 9, 2019 Benzinga -9.19%
Jul-08-19 08:00AM  Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019 PR Newswire +61.85%
Jul-02-19 08:00AM  Soliton Announces Filing of Form S-1 Registering the Shares Issued in Private Placement at $14.00 per Unit PR Newswire -9.48%
Jul-01-19 08:00AM  Soliton Partners with Capital Laser and Skin Care to Advance Pivotal Cellulite Trial PR Newswire -5.99%
Jun-28-19 02:19PM  18 Stocks Joining The Russell Indices Benzinga
08:00AM  Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today PR Newswire
Jun-25-19 08:00AM  Soliton Engages CRO to begin Pivotal Cellulite Trial PR Newswire
Jun-18-19 01:03PM  Soliton to be Added to the Russell 2000 and 3000 Indexes on June 28, 2019 PR Newswire
Jun-17-19 09:15AM  Soliton Announces $9.45 Million Private Placement PR Newswire +16.36%
Jun-12-19 08:30AM  Soliton Announces Long-Term Cellulite Trial Results to be Presented at The Aesthetics Show on July 11-14, 2019 PR Newswire -10.40%
Jun-11-19 08:30AM  Soliton Confirms Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance for Today at 4:30 PM ET PR Newswire
Jun-05-19 08:00AM  Soliton Announces Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance PR Newswire -6.00%
Jun-04-19 08:00AM  Soliton Announces Significant Discovery of Acoustic Subcision for Treatment of Cellulite PR Newswire +22.05%
May-30-19 04:26PM  Why Soliton's Shares Went on a Roller Coaster Ride Today Motley Fool -7.79%
May-29-19 12:06PM  Soliton Tattoo Removal Device: SOLY Stock Skyrockets on FDA Approval InvestorPlace +42.62%
10:39AM  Companies to Watch: Canada Goose misses, Intel unveils new chips, Soliton soars on FDA approval Yahoo Finance
10:30AM  Medtech Firm Extends 300% Surge on Cellulite, Tattoo Device Hope Bloomberg
10:00AM  Stock Market Tumbles At Open, Breaks Below Key Levels Investor's Business Daily
09:33AM  Soliton Soars a Second Day After FDA Approves Tattoo Removal Device TheStreet.com
08:00AM  Soliton to Initiate Pivotal Cellulite Trial after Positive Proof-of-Concept Trial Results with 20-47% Improvement in Cellulite Severity Score PR Newswire
07:29AM  Dow Jones Futures Fall: Stock Market Correction Poised To Hit New Lows Investor's Business Daily
May-28-19 05:27PM  Stocks making the biggest moves after hours: Workday, Inovio and more CNBC +148.17%
12:45PM  Soliton Rallies On FDA Approval For Tattoo Removal Device Benzinga
10:19AM  Soliton Receives FDA 510(k) Clearance of its Acoustic Shockwave RAP Device PR Newswire
May-17-19 11:57AM  Soliton Responds To Blog Calling It A 'PR Machine' Benzinga
08:00AM  Soliton Provides FDA Update and Addresses Recent Anonymous Article PR Newswire
May-16-19 08:00AM  Soliton's RAP Device Able to Penetrate Vacuole Shielding; Targets $4 Billion Potential Tattoo Removal Market PR Newswire -31.50%
May-14-19 02:39PM  Biotech Brief: Most Recent Technological Advancements Pushing U.S. Medical Device Market to New Levels PR Newswire -6.94%
08:30AM  Soliton Receives Approval for New Patent for its Acoustic Shockwave Technology PR Newswire
May-13-19 05:05PM  Fighting cellulite and removing tattoos with sound waves Yahoo Finance Video -16.25%
10:31AM  Global market to combat cellulite to reach $1.4B by 2026 Yahoo Finance Video
May-09-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire +6.76%
May-01-19 08:00AM  Soliton Announces Completion of New Replaceable Cartridge to Target Cellulite Reduction PR Newswire +6.73%
Apr-23-19 08:00AM  Soliton Announces Global Partner Completes Second Generation RAP Device to More Effectively Target Cellulite Reduction PR Newswire +11.64%
Apr-18-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire -9.99%
Apr-15-19 08:00AM  Soliton Announces Cellulite Trial Results to be Presented at National Aesthetics Conference on May 11, 2019 PR Newswire +14.55%
Apr-09-19 08:00AM  Soliton Completes Cellulite Clinical Trials PR Newswire
Apr-04-19 08:00AM  Soliton Receives European Patent for Acoustic Shockwave Technology PR Newswire +11.11%
Apr-01-19 08:00AM  Soliton Initiated Clinical Trials for Treatment of Cellulite in Humans PR Newswire +10.74%
Mar-27-19 08:00AM  Soliton Receives FDA Acceptance for 510(k) Application PR Newswire
Mar-21-19 08:00AM  Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device PR Newswire +8.16%
Mar-19-19 08:00AM  Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication PR Newswire +17.55%
Mar-18-19 08:00AM  Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-14-19 08:00AM  Soliton Partners with Sanmina, a Global Medical Device Manufacturer ACCESSWIRE +10.00%
Mar-12-19 08:00AM  Soliton to Ring the Nasdaq Stock Market Closing Bell on March 19, 2019 ACCESSWIRE
Mar-08-19 08:00AM  Soliton's RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation ACCESSWIRE
Mar-04-19 07:00AM  Soliton Receives FDA Approval for Small Business Designation ACCESSWIRE
Feb-28-19 07:00AM  Soliton Discusses Rapid Acoustic Pulse Technology for Treatment of Cellulite GlobeNewswire +6.85%
Feb-26-19 07:30AM  Soliton Receives Additional Patent for Breakthrough Acoustic Shockwave Technology GlobeNewswire
Feb-19-19 12:03PM  Soliton, Inc. Completes IPO and Begins Trading on Nasdaq Under Ticker Symbol SOLY GlobeNewswire
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.